BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 23496844)

  • 1. Leptomeningeal and intramedullary metastases of glioblastoma multiforme in a patient reoperated during adjuvant radiochemotherapy.
    Grah JJ; Katalinic D; Stern-Padovan R; Paladino J; Santek F; Juretic A; Zarkovic K; Plestina S; Supe M
    World J Surg Oncol; 2013 Mar; 11():55. PubMed ID: 23496844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain Stem and Entire Spinal Leptomeningeal Dissemination of Supratentorial Glioblastoma Multiforme in a Patient during Postoperative Radiochemotherapy: Case Report and Review of the Literatures.
    Kong X; Wang Y; Liu S; Chen K; Zhou Q; Yan C; He H; Gao J; Guan J; Yang Y; Li Y; Xing B; Wang R; Ma W
    Medicine (Baltimore); 2015 Jun; 94(24):e962. PubMed ID: 26091464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meningeal seeding from glioblastoma multiforme treated with radiotherapy and temozolomide.
    Kuo LT; Tsai SY; Yang CY; Lin LW
    Asian J Surg; 2017 Jan; 40(1):61-65. PubMed ID: 23978432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy and bevacizumab for intramedullary and leptomenigeal metastatic glioblastoma: a case report and review of the literature.
    Fiorentino A; Caivano R; Chiumento C; Cozzolino M; Fusco V
    Int J Neurosci; 2012 Nov; 122(11):691-4. PubMed ID: 22720749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptomatic leptomeningeal and intramedullary metastases from intracranial glioblastoma multiforme: a case report.
    Scoccianti S; Detti B; Meattini I; Iannalfi A; Sardaro A; Leonulli BG; Martinelli F; Bordi L; Pellicanò G; Biti G
    Tumori; 2008; 94(6):877-81. PubMed ID: 19267111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive Leptomeningeal Intracranial and Spinal Metastases in a Patient with a Supratentorial Glioblastoma Multiforme, IDH-Wildtype.
    Schwartz C; Romagna A; Machegger L; Weiss L; Huemer F; Fastner G; Kleindienst W; Weis S; Greil R; Winkler PA
    World Neurosurg; 2018 Dec; 120():442-447. PubMed ID: 30253992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme.
    Jastaniyah N; Murtha A; Pervez N; Le D; Roa W; Patel S; Mackenzie M; Fulton D; Field C; Ghosh S; Fallone G; Abdulkarim B
    Radiat Oncol; 2013 Feb; 8():38. PubMed ID: 23425509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant chemoradiotherapy followed by adjuvant temozolomide improves survival in glioblastoma multiforme.
    Abrey LE
    Curr Neurol Neurosci Rep; 2005 May; 5(3):167-8. PubMed ID: 15865881
    [No Abstract]   [Full Text] [Related]  

  • 9. Leptomeningeal spinal metastases from glioblastoma multiforme: treatment and management of an uncommon manifestation of disease.
    Lawton CD; Nagasawa DT; Yang I; Fessler RG; Smith ZA
    J Neurosurg Spine; 2012 Nov; 17(5):438-48. PubMed ID: 22958073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Far-distant metastases along the CSF pathway of glioblastoma multiforme during continuous low-dose chemotherapy with temozolomide and celecoxib.
    Seiz M; Nölte I; Pechlivanis I; Freyschlag CF; Schmieder K; Vajkoczy P; Tuettenberg J
    Neurosurg Rev; 2010 Jul; 33(3):375-81; discussion 381. PubMed ID: 20306105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged survival of a patient with cervical intramedullary glioblastoma multiforme treated with total resection, radiation therapy, and temozolomide.
    Tseng HM; Kuo LT; Lien HC; Liu KL; Liu MT; Huang CY
    Anticancer Drugs; 2010 Nov; 21(10):963-7. PubMed ID: 20838208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG PET/CT in Recurrent Glioblastoma Multiforme With Leptomeningeal and Diffuse Spinal Cord Metastasis.
    Malik D
    Clin Nucl Med; 2021 Feb; 46(2):138-139. PubMed ID: 33234937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: the CLEOPATRA trial.
    Combs SE; Kieser M; Rieken S; Habermehl D; Jäkel O; Haberer T; Nikoghosyan A; Haselmann R; Unterberg A; Wick W; Debus J
    BMC Cancer; 2010 Sep; 10():478. PubMed ID: 20819220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiforme.
    Reddy K; Damek D; Gaspar LE; Ney D; Waziri A; Lillehei K; Stuhr K; Kavanagh BD; Chen C
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):655-60. PubMed ID: 22483738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drop metastases to the spinal cord from infratentorial glioblastoma multiforme in post-temozolomide era.
    Pande SB; Pavithran K
    J Cancer Res Ther; 2015; 11(4):1039. PubMed ID: 26881656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time trends in glioblastoma multiforme survival: the role of temozolomide.
    Dubrow R; Darefsky AS; Jacobs DI; Park LS; Rose MG; Laurans MS; King JT
    Neuro Oncol; 2013 Dec; 15(12):1750-61. PubMed ID: 24046259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Features and Outcomes of Primary Spinal Cord Glioblastoma: A Single-Center Experience and Literature Review.
    Yang K; Man W; Jing L; Sun Z; Liang P; Wang J; Wang G
    World Neurosurg; 2020 Nov; 143():e157-e165. PubMed ID: 32688042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of surgery on the efficacy of adjuvant therapy in glioblastoma multiforme.
    Brzozowska A; Toruń A; Mazurkiewicz M
    Adv Clin Exp Med; 2015; 24(2):279-87. PubMed ID: 25931361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution.
    Michaelsen SR; Christensen IJ; Grunnet K; Stockhausen MT; Broholm H; Kosteljanetz M; Poulsen HS
    BMC Cancer; 2013 Sep; 13():402. PubMed ID: 24004722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical review of treatment outcomes in glioblastoma multiforme--the validation in a non-trial population of the results of a randomised Phase III clinical trial: has a more radical approach improved survival?
    Rock K; McArdle O; Forde P; Dunne M; Fitzpatrick D; O'Neill B; Faul C
    Br J Radiol; 2012 Sep; 85(1017):e729-33. PubMed ID: 22215883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.